NPI: 1023081999 · NOGALES, AZ 85621 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/09/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/09/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 28,288 | $741K |
| 2019 | 32,426 | $614K |
| 2020 | 33,530 | $670K |
| 2021 | 22,962 | $431K |
| 2022 | 29,178 | $445K |
| 2023 | 16,045 | $720K |
| 2024 | 7,732 | $535K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 53,586 | 3,919 | $3.95M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 634 | 423 | $204K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 34,395 | 2,380 | $4K |
| A4657 | Syringe, with or without needle, each | 26,804 | 2,996 | $2K |
| 82108 | 223 | 169 | $0.00 | |
| 85048 | 521 | 452 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 10,336 | 2,354 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 19,309 | 1,395 | $0.00 |
| 83540 | 240 | 189 | $0.00 | |
| 85041 | 521 | 451 | $0.00 | |
| 90662 | 166 | 138 | $0.00 | |
| 83970 | 216 | 174 | $0.00 | |
| 90670 | 35 | 27 | $0.00 | |
| 83550 | 240 | 189 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 46 | 31 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 40 | 32 | $0.00 |
| 82728 | 252 | 200 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 22,169 | 1,690 | $0.00 |
| 90674 | 89 | 70 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 228 | 191 | $0.00 |
| 90747 | 12 | 12 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 87 | 46 | $0.00 |
| G0010 | Administration of hepatitis b vaccine | 12 | 12 | $0.00 |